We treated HCT116 tumor cells with either napabucasin or PS-acet.-STAT3 peptide, followed by Western blotting to assess phosphorylated STAT3 (p-STAT3) and p-STAT5 levels. This evidence concerns the gene STAT3 and neoplasm.